Physician profile
Janel Wright
NPI 1942527908
$1,226.99
in general payments reported to CMS, 2019-2025
20 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $277 · 2023: $205 · 2024: $360 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636 · Education: $96.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.97 |
| Education | $96.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $231.10 | 2022-2024 | Xospata |
| Takeda Pharmaceuticals U.S.A., INC. | $199.98 | 2021 | |
| Daiichi Sankyo INC. | $138.66 | 2023-2025 | Enhertu |
| Abbvie INC. | $120.37 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $93.18 | 2023-2024 | Keytruda, Lynparza, Welireg |
| Taiho Oncology, INC. | $52.22 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $44.00 | 2021-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $39.60 | 2023 | Epkinly, Imbruvica |
| Pharmaessentia USA Corporation | $33.73 | 2024 | Besremi |
| Exelixis INC. | $31.47 | 2024 | Cabometyx |
| Blueprint Medicines Corporation | $29.11 | 2024 | Ayvakit |
| Amgen INC. | $28.11 | 2022 | |
| Seagen INC. | $27.77 | 2023 | Adcetris |
| Eisai INC. | $26.66 | 2024 | |
| Genmab U.S., INC. | $25.39 | 2024 | Epkinly |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $23.58 | 2024 | Lynparza |
| Verity Pharmaceuticals INC. | $22.55 | 2023 | Trelstar |
| Genentech USA, INC. | $22.03 | 2023 | Tecentriq |
| Lilly USA, LLC | $21.59 | 2024 | Jaypirca, Verzenio |
| Novocure INC. | $15.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janel Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.